E. Triau

α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease

B. Strooper, R. Dom, F. Leuven, 1993, Neurobiology of Aging.

P.4.046 Donepezil-treated Alzheimer's disease patients with apparent initial cognitive decline demonstrate significant benefits when therapy is continued: Results from a randomized, placebo-controlled trial

A. Kurz, P. Johannsen, C. Kalisvaart, 2003, European Neuropsychopharmacology.

alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.

B. de Strooper, R. Dom, F. van Leuven, 1993, Neurobiology of aging.